{
    "nct_id": "NCT04388371",
    "official_title": "Glutamine PET Imaging in LAM",
    "inclusion_criteria": "1. Female subjects\n2. ≥ 18 years of age\n3. Diagnosis of LAM via either a. Histopathologic diagnosis b. Compatible CT chest and one of the following i. Tuberous Sclerosis Complex* ii. Angiomyolipoma or lymphangioma iii. Chylous Effusion iv. Serum VEGF-D level >800 pg/mL\n\n   * The diagnosis of TSC will be based on the presence of at least two major criteria or one major and one or more minor features per published guidelines.(30)\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Patients with any known intrathoracic cancer (primary lung cancer or metastatic disease) or undergoing active treatment for malignancy\n2. Patients with use of investigational therapies for LAM either currently or in the prior 3 months\n3. Patients with body weight ≥400 pounds or body habitus or disability that will not permit the imaging protocol to be performed\n4. Patients known to be pregnant or breastfeeding\n5. Patients with clinically active known or suspected pulmonary infection of any type\n6. Patients known or suspected to have any inborn error of metabolism\n7. Patients with known type I diabetes mellitus\n8. Patients who cannot have a peripheral IV for any reason\n9. Patients who cannot lie flat for the duration of the PET scan\n10. Patients who are claustrophobic\n11. Patients with a prior allergy to contrast agents or to PET tracers",
    "miscellaneous_criteria": ""
}